seed
Stage
1
Investors
About
Prolevi Bio develops a modified release thyroid hormone tablet formulation that mimics natural hormone release cycles, using mathematical models to tailor treatment to individual patient needs, aiming to improve outcomes for patients with hypothyroidism who do not respond to current treatments.
Explore Prolevi Bio's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.